Target intelligence / Profile preview

Golgi membrane protein 1 (GOLM1 (also commonly known as GOLPH2 or GP73))

Target
GOLM1 (also commonly known as GOLPH2 or GP73)
Molecular classification
Other (Golgi transmembrane protein, not a receptor, enzyme, ion channel, or transporter; no evidence supporting functional activity fitting these families)
01

Overview

Golgi membrane protein 1 (GOLM1), also known as Golgi phosphoprotein 2 (GOLPH2) or GP73, is a type II transmembrane glycoprotein primarily found in the cis and medial Golgi of epithelial cells[1][5][7][10]. It participates in protein processing and trafficking through the Golgi apparatus and shows increased expression in response to viral infections and various cancers. Its soluble, cleaved form can be detected in blood and is under investigation as a sensitive biomarker for liver disease (notably hepatocellular carcinoma), as well as several other malignancies[2][6][8][10]. While its precise molecular function is not fully elucidated, there is evidence it may suppress immune responses, participate in cell migration/invasion in epithelial cancers, and interact with secretory clusterin[4][9][10]. GOLM1 is highly conserved and possesses unusual heat and protease resistance due to its helical structure[5][10].

Other names
GOLM1GP73GOLPH2C9orf155HEL46PSEC0257bA379P1.3
02

Mechanism of action

Not established; functions as a biomarker rather than a drug target, but may modulate immune response and cell migration/invasion in cancer

03

Biological functions

Protein trafficking/modification in the GolgiCellular response to viral infectionPotential role in epithelial-mesenchymal transition and cell migration/invasionRegulation of immune responses (e.g., suppression of Th1 response)
04

Disease associations

Cancer (e.g., hepatocellular carcinoma, prostate cancer, renal cell carcinoma, seminoma, lung cancer, gastric cancer)Infection (upregulated in response to viral infection)Other (regulation in metabolic diseases and immunological responses implied)
05

Safety considerations

None reported for therapeutic targeting; as a diagnostic biomarker, presents no direct safety risks
06

Interacting drugs

None specifically identified in current literature; primarily used as a biomarker, not a direct drug target
07

Biomarkers

Serum GP73/GOLPH2/GOLM1 is used for diagnosis and prognosis in hepatocellular carcinoma and potentially other cancersFucosylated forms of GP73 in liver cancer

Beyond the preview

Go deeper on Golgi membrane protein 1 (GOLM1 (also commonly known as GOLPH2 or GP73)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golgi membrane protein 1 (GOLM1 (also commonly known as GOLPH2 or GP73)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call